| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Tirofiban | Tirofiban Impurity A | VL2720001 | View CAS 149490-60-8 |
| Tirofiban | Tirofiban Impurity B | VL2720002 | View CAS 149463-65-0 |
Tirofiban Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Tirofiban | Tirofiban Impurity A | VL2720001 | View CAS 149490-60-8 |
| Tirofiban | Tirofiban Impurity B | VL2720002 | View CAS 149463-65-0 |
| Catalogue No. | VL2720002 |
| CAS No. | 149463-65-0 |
| Molecular Formula | C9H13Cl2N |
| Molecular Weight | 206.11 |
| Parent drug | Tirofiban |
| IUPAC Name | 4-(4-chlorobutyl)pyridine Hydrochloride |
| Synonyms | N/A |
| References | Sci-Hub, Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials, 10.1093/eurheartj/ehp376. (2022). Retrieved January 28, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1093/eurheartj/ehp376 ? |
| Status | In-stock |
| ListName | Tirofiban Impurity B |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
